| Literature DB >> 32187332 |
Heber Silva-Díaz1, Emma V Arriaga-Deza1, Virgilio E Failoc-Rojas2, Yessica R Alarcón-Flores3, Sara Y Rojas-Rojas3, Lizzie K Becerra-Gutiérrez4, Katya M Mera-Villasis4, Franklin R Aguilar-Gamboa4, Teresa Silva-García3.
Abstract
INTRODUCTION: Toxoplasmosis is a zoonosis caused by Toxoplasma gondii. This study investigated the prevalence and factors associated with toxoplasmosis among pregnant women.Entities:
Year: 2020 PMID: 32187332 PMCID: PMC7094055 DOI: 10.1590/0037-8682-0164-2019
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN: 0037-8682 Impact factor: 1.581
Clinical-epidemiological characteristics of pregnant women treated in a hospital or in the community of Lambayeque, Peru between 2016 and 2017
| Community | Hospital | Total | ||||
|---|---|---|---|---|---|---|
| Characteristic | n | % | n | % | n | % |
|
| 28 | (9) | 24.7 | (11) | 25.5 | (10) |
|
| ||||||
| Urban | 96 | 100 | 0 | 0 | 96 | 44.1 |
| Rural | 7 | 5.74 | 115 | 94.26 | 122 | 55.9 |
|
| ||||||
| Non-drinking | 60 | 44.12 | 76 | 55.88 | 136 | 62.4 |
| Drinking | 43 | 52.44 | 39 | 47.56 | 82 | 37.69 |
|
| ||||||
| Yes | 27 | 36.99 | 46 | 63.01 | 73 | 33.5 |
| No | 76 | 52.41 | 69 | 47.59 | 145 | 66.5 |
|
| ||||||
| Yes | 45 | 39.47 | 69 | 60.53 | 114 | 52.3 |
| No | 58 | 55.77 | 46 | 44.23 | 104 | 47.7 |
|
| ||||||
| Yes | 88 | 44.9 | 108 | 55.1 | 196 | 89.9 |
| No | 15 | 68.18 | 7 | 31.82 | 22 | 10.1 |
|
| ||||||
| First trimester | 17 | 29.31 | 41 | 70.69 | 58 | 26.6 |
| Second trimester | 32 | 47.76 | 35 | 52.24 | 67 | 30.8 |
| Third trimester | 54 | 58.06 | 39 | 41.94 | 93 | 42.6 |
|
| ||||||
| Yes | 16 | 59.26 | 11 | 40.74 | 27 | 12.38 |
| No | 53 | 33.76 | 104 | 66.24 | 157 | 72.02 |
| Not mentioned | 31 | 100 | 0 | 0 | 34 | 15.6 |
|
| ||||||
| Yes | 35 | 70 | 15 | 30 | 50 | 22.9 |
| No | 68 | 40.48 | 100 | 59.52 | 168 | 77.1 |
|
| ||||||
| Yes | 3 | 14.29 | 18 | 15.65 | 21 | 9.63 |
| No | 65 | 40.12 | 97 | 59.88 | 162 | 74.31 |
| Not mentioned | 35 | 35 | 0 | 0 | 35 | 16.05 |
|
| ||||||
| Yes | 14 | 66.67 | 7 | 33.33 | 21 | 9.63 |
| No | 125 | 63.45 | 72 | 36.54 | 191 | 90.4 |
|
| ||||||
| Yes | 3 | 11.11 | 24 | 88.89 | 27 | 12.4 |
| No | 80 | 41.88 | 111 | 58.12 | 191 | 87.6 |
*Non-parametric variable, Shapiro-Wilk <0.05. Age is reported by median and the interquartile range.
Frequency and bivariate analysis of the presence of anti-T.gondii antibodies among pregnant women treated in a hospital or in the community of Lambayeque, Peru from 2016 to 2017.
| Positive to toxoplasma+ (%) | Negative to toxoplasma (%) | Crude model | p-value | |||
|---|---|---|---|---|---|---|
| Characteristic | n | % | n | % | PR [95% CI] | |
|
| 78 (35.8%) | 140 (64.2%) | ||||
|
| 27 [23-33] | 27 [23-33] | 1.02 [0.97 - 1.08] | 0.328 | ||
|
| ||||||
| Urban | 38 (39.6) | 58 (60.4) | 1.2 [0.84 - 1.72] | 0.298 | ||
| Rural | 40 (32.8) | 82 (67.2) | 1 | |||
|
| ||||||
| Non-drinking | 57 (41.9) | 79 (58.1) | 1.63 [1.07 -2.48] | 0.015 | ||
| Drinking | 21 (25.6) | 61 (74.4) | 1 | |||
|
| ||||||
| Yes | 24 (32.9) | 49 (67.1) | 0.88 [0.59 -1.30] | 0.525 | ||
| No | 54 (37.2) | 91 (62.8) | 1 | |||
|
| ||||||
| Yes | 43 (37.7) | 71 (62.3) | 1.12 [0.78-1.6] | 0.531 | ||
| No | 35 (33.7) | 69 (66.3) | 1 | |||
|
| ||||||
| Yes | 72 (36.7) | 124 (63.3) | 1.34 [0.66-2.73] | 0.38 | ||
| No | 6 (27.3) | 16 (72.7) | 1 | |||
|
| ||||||
| First trimester | 20 (35.1) | 37 (64.9) | 1 | |||
| Second trimester | 26 (38.2) | 41 (61.8) | 1.06 [0.57 - 1.84] | 0.919 | ||
| Third trimester | 32 (34.4) | 61 (65.6) | 0.95 [0.54 - 1.64] | 0.856 | ||
|
| ||||||
| Yes | 13 | 17.11 | 63 | 82.89 | 1.43 [0.92 - 2.23] | 0.136 |
| No | 14 | 10.7 | 125 | 89.93 | 1 | |
|
| ||||||
| Yes | 15 | 30 | 35 | 70 | 0.8 [0.51 - 1.27] | 0.331 |
| No | 63 | 37.5 | 105 | 62.5 | 1 | |
|
| ||||||
| Yes | 8 | 38.1 | 13 | 61.9 | 1.03 [0.45 -2.31] | 0.948 |
| No | 70 | 35.5 | 92 | 64.5 | 1 | |
|
| ||||||
| Yes | 7 | 33.3 | 14 | 66.7 | 0.94 [0.49 - 1.79] | 0.867 |
| No | 71 | 36 | 126 | 64 | 1 | |
|
| ||||||
| Yes | 11 | 40.7 | 16 | 59.3 | 1.23 [0.74 -2.04] | 0.441 |
| No | 67 | 35.1 | 124 | 64.9 | 1 | |
*The median is used because it is a non-parametric variable (Kolmorov-Smirnov test<0.05). ‡The Chi-square test was used. +Positive meant there were anti-T. gondii IgM or IgG antibodies. Anti-Toxoplasma gondii; PR: Prevalence ratio; CI: Confidence interval.
Factors associated with the presence of anti-T.gondii antibodies among pregnant women treated in a hospital and in the community of Lambayeque, Peru from 2016 to 2017.
| Adjusted model* | P-value | |
|---|---|---|
| RPa [95% CI] | ||
|
| ||
| Urban | 1.20 [1.13 - 1.30] | 0.001 |
| Rural | ref. | |
|
| ||
| Non-drinking | 1.80 [1.67 -1.94] | 0.001 |
| Drinking | Ref. | |
|
| ||
| Yes | 0.94 [0.82 -1.07] | 0.354 |
| No | Ref. | |
|
| ||
| Yes | 1.38 [1.12 - 1.71] | 0.003 |
| No | Ref. |
*We conducted a generalized linear model with Poisson family, adjusted by the variables presented, and adjusted by cluster. +We only included variables with a likelihood ratio test lower than 0.20 in the raw analysis (consumption of non-drinking water, threatened abortion), and variables that may be explained by mechanisms of pathogenicity (area of residence, household cats). Anti-T. gondii: Anti-Toxoplasma gondii. PRa: Prevalence ratio adjusted; CI: Confidence interval; Ref: referrer.